Acchioni C, Sandini S, Acchioni M, Sgarbanti M
Pathogens. 2024; 13(5).
PMID: 38787201
PMC: 11124504.
DOI: 10.3390/pathogens13050349.
Du Y, Wang C, Zhang Y
Viruses. 2022; 14(12).
PMID: 36560647
PMC: 9784482.
DOI: 10.3390/v14122645.
Harris M, Ratnapriya S, Chov A, Cervera H, Block A, Gu C
Cell Rep. 2020; 31(10):107749.
PMID: 32521274
PMC: 7336836.
DOI: 10.1016/j.celrep.2020.107749.
Ding S, Gasser R, Gendron-Lepage G, Medjahed H, Tolbert W, Sodroski J
J Virol. 2019; 93(22).
PMID: 31484748
PMC: 6819941.
DOI: 10.1128/JVI.01403-19.
Kumar N, Sharma S, Barua S, Tripathi B, Rouse B
Clin Microbiol Rev. 2018; 31(4).
PMID: 29976554
PMC: 6148187.
DOI: 10.1128/CMR.00111-17.
Multiplex single-cell visualization of nucleic acids and protein during HIV infection.
Puray-Chavez M, Tedbury P, Huber A, Ukah O, Yapo V, Liu D
Nat Commun. 2017; 8(1):1882.
PMID: 29192235
PMC: 5709414.
DOI: 10.1038/s41467-017-01693-z.
Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail.
Bhatia A, Kaushik R, Campbell N, Pontow S, Ratner L
Virology. 2008; 384(1):233-41.
PMID: 19059618
PMC: 2651518.
DOI: 10.1016/j.virol.2008.10.047.
Differential control of CXCR4 and CD4 downregulation by HIV-1 Gag.
Valiathan R, Resh M
Virol J. 2008; 5:23.
PMID: 18267010
PMC: 2262066.
DOI: 10.1186/1743-422X-5-23.
Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrix.
Bhatia A, Campbell N, Panganiban A, Ratner L
Virology. 2007; 369(1):47-54.
PMID: 17706261
PMC: 2211416.
DOI: 10.1016/j.virol.2007.06.046.
HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles.
LeGoff J, Bouhlal H, Lecerf M, Klein C, Hocini H, Si-Mohamed A
Virol J. 2007; 4:2.
PMID: 17207276
PMC: 1769478.
DOI: 10.1186/1743-422X-4-2.
Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.
Wildum S, Schindler M, Munch J, Kirchhoff F
J Virol. 2006; 80(16):8047-59.
PMID: 16873261
PMC: 1563805.
DOI: 10.1128/JVI.00252-06.
Retroviral superinfection resistance.
Nethe M, Berkhout B, van der Kuyl A
Retrovirology. 2005; 2:52.
PMID: 16107223
PMC: 1224871.
DOI: 10.1186/1742-4690-2-52.
Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen.
Walters K, Joyce M, Addison W, Fischer K, Tyrrell D
J Virol. 2004; 78(15):7925-37.
PMID: 15254165
PMC: 446106.
DOI: 10.1128/JVI.78.15.7925-7937.2004.
Dynamics of HIV-1 recombination in its natural target cells.
Levy D, Aldrovandi G, Kutsch O, Shaw G
Proc Natl Acad Sci U S A. 2004; 101(12):4204-9.
PMID: 15010526
PMC: 384719.
DOI: 10.1073/pnas.0306764101.
Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.
West J, Weldon S, Wyss S, Lin X, Yu Q, Thali M
J Virol. 2002; 76(7):3338-49.
PMID: 11884559
PMC: 136014.
DOI: 10.1128/jvi.76.7.3338-3349.2002.
Adaptation of chimeric retroviruses in vitro and in vivo: isolation of avian retroviral vectors with extended host range.
Barsov E, Payne W, Hughes S
J Virol. 2001; 75(11):4973-83.
PMID: 11333876
PMC: 114900.
DOI: 10.1128/JVI.75.11.4973-4983.2001.
RNAs from genetically distinct retroviruses can copackage and exchange genetic information in vivo.
Yin P, Hu W
J Virol. 1997; 71(8):6237-42.
PMID: 9223525
PMC: 191891.
DOI: 10.1128/JVI.71.8.6237-6242.1997.
Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.
Volsky D, Simm M, Shahabuddin M, Li G, Chao W, Potash M
J Virol. 1996; 70(6):3823-33.
PMID: 8648718
PMC: 190259.
DOI: 10.1128/JVI.70.6.3823-3833.1996.
Pathogenesis of human immunodeficiency virus infection.
Levy J
Microbiol Rev. 1993; 57(1):183-289.
PMID: 8464405
PMC: 372905.
DOI: 10.1128/mr.57.1.183-289.1993.
Productive expression state confers resistance of human immunodeficiency virus (HIV)-2-infected lymphoma cells against superinfection by HIV-1.
von Dalnok G, Kleinschmidt A, Neumann M, Erfle V, Brack-Werner R
Arch Virol. 1993; 131(3-4):419-29.
PMID: 8347081
DOI: 10.1007/BF01378642.